Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Arecor Therape (AREC) Regulatory News

Date Source Headline
9th May 2024 7:00 am RNS Arecor and Medtronic Diabetes collaboration
3rd May 2024 4:44 pm RNS Publication of Full Year Financial Results delayed
29th Apr 2024 7:00 am RNS Notice of results
23rd Apr 2024 7:00 am RNS BOARD CHANGE
12th Mar 2024 8:58 am RNS Arecor and TRx Biosciences research collaboration
12th Mar 2024 7:00 am RNS Arecor and TRx Biosciences research collaboration
29th Feb 2024 7:00 am RNS Arecor announces launch of Ogluo® in Netherlands
1st Feb 2024 7:00 am RNS Year End Trading Update
23rd Jan 2024 4:58 pm RNS Arecor announces update on INBRX-101
18th Jan 2024 7:00 am RNS Arecor granted key European patent
8th Jan 2024 7:00 am RNS Expansion of specialty hospital collaboration
3rd Jan 2024 7:00 am RNS Appointment of SVP for Tetris Pharma Ltd
4th Dec 2023 7:00 am RNS Agreement with global medical products company
29th Nov 2023 7:00 am RNS Arecor Continues Collaboration with Lilly
17th Nov 2023 7:00 am RNS Product with Arestat technology launched in Europe
2nd Nov 2023 7:00 am RNS Inhibrx milestone triggers payment to Arecor
1st Nov 2023 3:31 pm RNS Exercise of rollover options & Total Voting Rights
2nd Oct 2023 7:00 am RNS Progress of Phase I clinical study of AT278
15th Sep 2023 7:00 am RNS Arecor on Investor Meet Company Platform
14th Sep 2023 7:00 am RNS Interim Results for six months ended 30 June 2023
7th Sep 2023 7:00 am RNS Arecor: positive Hikma FDA pre-IND meeting
4th Sep 2023 7:00 am RNS TETRIS PHARMA ANNOUNCES AGREEMENT WITH GOODLIFE
17th Aug 2023 7:00 am RNS Collaboration With Top 10 Global Pharma
10th Aug 2023 7:00 am RNS Notice of Interim Results
20th Jul 2023 7:00 am RNS Arecor Business Update
5th Jul 2023 7:00 am RNS Additional Agreement with Leading Biopharma
27th Jun 2023 7:00 am RNS Arecor granted key patents in Europe and China
26th Jun 2023 7:00 am RNS Arecor presents positive data for AT247 at ADA
9th Jun 2023 3:35 pm RNS Exercise of rollover options & Total Voting Rights
9th Jun 2023 12:43 pm RNS Result of AGM
9th Jun 2023 7:00 am RNS AGM Statement
24th May 2023 7:00 am RNS Director/PDMR Shareholding
15th May 2023 7:00 am RNS TETRIS PHARMA LAUNCHES OGLUO® IN DENMARK & NORWAY
4th May 2023 4:00 pm RNS ARECOR 2022 ANNUAL REPORT AND NOTICE OF AGM
26th Apr 2023 7:00 am RNS Arecor Granted Key U.S Patent
21st Apr 2023 7:00 am RNS Arecor on Investor Meet Company Platform
20th Apr 2023 7:00 am RNS Unaudited Preliminary Results for 2022
5th Apr 2023 7:00 am RNS Arecor Appoints Chief Business Officer
22nd Mar 2023 7:00 am RNS FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL
13th Mar 2023 4:35 pm RNS Price Monitoring Extension
FTSE 100 Latest
Value8,801.29
Change14.27